Visalytics
Visalytics
approved EB-2 (NIW)

Research Fellow

Biochemistry · China · 2025-04-30

Processing Time
320 days
Decision Date
2025-04-30
Location
Massachusetts
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to investigate axon degeneration with a focus on the SARM1 signaling pathway, which is a central driver of nerve damage in chemotherapy patients. The work aims to develop therapeutic tools to mitigate chemotherapy-induced peripheral neuropathy (CIPN) to improve the quality of life for cancer patients.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research addresses chemotherapy-induced peripheral neuropathy, a major complication for cancer patients, representing a significant national health issue.

2 Well-positioned to Advance the Endeavor Met

The petitioner has a demonstrated record of impactful publications in top-tier journals and active collaboration in high-level research.

3 Balance of Factors Met

The petitioner’s contributions to DNA biosensing and neurobiology, combined with her specialized expertise, make it beneficial to waive the labor certification requirement.

Why This Petition Was Approved

The approval was based on the petitioner's 6 peer-reviewed journal articles and 1 preprint in top-tier journals like Science, which garnered 78 citations. Additionally, the petitioner demonstrated national importance through peer review service for scientific journals and research roles supported by major national and international funding bodies. The case satisfied all three Dhanasar prongs without delay.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Grants
Judging Experience
Original Contributions

Similar Cases

Scientist

Research and Development · Hong Kong

WeGreened EB-2 (NIW) approved
Massachusetts 80 days 2022-04-23
The petitioner proposes to continue research on developing and improving oncology and neurology drugs and treatment methods. The work focuses on validating new therapeutic targets and developing molecular treatments for prominent diseases, including cancer, to improve global public health outcomes.
View Case

Scientist

Research and Development · India

WeGreened EB-2 (NIW) approved
Alabama 6 days 2024-03-07
The petitioner proposes to continue research using mouse model systems, high-resolution imaging, and molecular biology techniques to discover the mechanisms and molecular pathology of Parkinson’s disease. The work focuses on identifying effective therapeutic targets to improve patient quality of life and alleviate the economic burden associated with the condition.
View Case

Postdoctoral Researcher

Biotechnology · China

WeGreened EB-2 (NIW) approved
Texas 106 days 2022-05-04
The petitioner proposes to continue her research in disease genetics and cellular therapeutics, specifically investigating stem cell-based cancer therapeutics and developing functional biomarkers for cancer treatment. Her work focuses on determining the mechanisms underpinning the development of cancer and neurodegenerative diseases to reduce their global impact.
View Case

Doctor

Biotechnology · China

WeGreened EB-2 (NIW) rfe approved
484 days 2025-10-31
The petitioner proposes to continue critical research using cellular and molecular techniques to elucidate the mechanisms of neurodegenerative diseases. This work aims to facilitate the development of new and improved prognostic and diagnostic tools for medical applications.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Research and Development cases More cases from China

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-04-30.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 320 days
Criteria Met 3 / 3
Evidence Types 5

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in China All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist